Physician
Associated Anesthesiologists of Springfield
Associated Anesthesiologists of Springfield was paid $2.85M by Medicaid between Jan 2018 and Jun 2020, across 57 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoASSOCIATED ANESTHESIOLOGISTS OF SPRINGFIELD
SPRINGFIELD, OH 45503
SPRINGFIELD, OH 45503
33aNPI1770675936assigned 09/28/2006
33bProvider typePain Medicine (Anesthesiology) Physician
28Total paid$2.85M
24GClaims160,678
24DCodes billed57
24AFirst – last monthJan 2018 – Jun 2020
Compared with peers
Next to other Pain Medicine (Anesthesiology) Physician providers in Ohio
Rank by total paid#1 of 43
Median peer was paid$52K
This provider vs. median55×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 60,043 | $1.09M | |
| 2019 | 59,865 | $1.06M | |
| 2020 | 40,770 | $701K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 32,258 | 28,547 | $986K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 14% | 10,345 | 9,977 | $391K |
| 80361 | 4.5% | 6,986 | 6,746 | $129K | |
| 80346 | 3.9% | 5,179 | 5,008 | $111K | |
| 80365 | 2.5% | 6,887 | 6,665 | $71K | |
| 80349 | 2.0% | 5,670 | 5,478 | $58K | |
| 80355 | 2.0% | 5,445 | 5,270 | $57K | |
| 80354 | 1.9% | 5,280 | 5,089 | $54K | |
| 80373 | 1.9% | 5,122 | 4,950 | $53K | |
| 80348 | 1.8% | 4,921 | 4,757 | $51K | |
| 80363 | 1.8% | 2,694 | 2,586 | $50K | |
| 80353 | 1.7% | 4,883 | 4,719 | $50K |
45 more codes
| 80356 | 1.7% | 4,868 | $49K | |
| 80359 | 1.7% | 4,872 | $49K | |
| 80366 | 1.7% | 4,739 | $49K | |
| 99204 | Doctor's office visit, new patient (more involved) | 1.7% | 713 | $48K |
| 80358 | 1.7% | 4,747 | $48K | |
| 99214 | Doctor's office visit, returning patient (more involved) | 1.5% | 812 | $43K |
| 80372 | 1.5% | 4,037 | $42K | |
| 80345 | 1.4% | 4,014 | $41K | |
| 80360 | 1.4% | 4,004 | $41K | |
| 83992 | 1.4% | 2,691 | $39K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 1,565 | $30K |
| 80368 | <1% | 2,714 | $28K | |
| 80370 | <1% | 2,693 | $28K | |
| 80336 | <1% | 2,693 | $28K | |
| 80324 | <1% | 2,690 | $27K | |
| 80323 | <1% | 2,679 | $26K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,296 | $25K |
| 80364 | <1% | 1,326 | $24K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,852 | $22K |
| 80325 | <1% | 1,901 | $19K | |
| 80335 | <1% | 1,323 | $14K | |
| 97161 | <1% | 266 | $13K | |
| 80320 | <1% | 928 | $12K | |
| 64493 | <1% | 135 | $6K | |
| 97035 | <1% | 915 | $5K | |
| 80369 | <1% | 501 | $5K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 385 | $4K |
| 00731 | <1% | 39 | $4K | |
| 80339 | <1% | 366 | $4K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 387 | $4K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 749 | $3K |
| 64494 | <1% | 120 | $3K | |
| 97032 | <1% | 365 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 830 | $2K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 28 | $1K |
| 64495 | <1% | 65 | $1K | |
| 20610 | <1% | 21 | $534.38 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 40 | $367.38 |
| 62370 | <1% | 13 | $219.42 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 18 | $108.64 |
| 82962 | <1% | 19 | $22.53 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 33 | $2.09 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 0% | 30 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 263 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 263 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialABRAHAM, KAMEL (PRESIDENT)